Meetings Events & Conference Coordinators 19th Annual New Orleans Summer Cancer Meeting 2024

Meetings Events & Conference Coordinators 19th Annual New Orleans Summer Cancer Meeting 2024

Annual New Orleans Summer Cancer Meeting 2024

Include: 57 videos, size: 7.52 GB

Target Audience: oncologists, hematologists, radiation oncologists, surgical oncologists

Information:

The 19th Annual New Orleans Summer Cancer Meeting (NOSCM) 2024 is designed for a diverse group of professionals involved in oncology. The target audience includes:

• Oncologists
• Hematologists
• Radiation oncologists
• Surgical oncologists
• Medical oncologists
• Oncology nurses
• Pharmacists
• Researchers
• Other healthcare professionals involved in cancer care

This meeting aims to provide the latest updates and advancements in cancer treatment, prevention, and survivorship care.

Annual New Orleans Summer Cancer Meeting 2024

Topics:

• Acquired Inhibitors in Cancer- State-of-the Art Management.mp4
  Addressing Disparities in Access to Supportive Care During Cancer Treatment and Survivorship- An Integrative Approach.mp4
  ALK- First Line and Mechanism Of Resistance.mp4
  Antibody Drug Conjugates for HER2 Negative Breast Cancer- A Revolution in Chemotherapy for Breast Cancer.mp4
  Applying New Endocrine and Targeted Agents to the Treatment of Hormone Receptor Positive, HER2 Negative Breast Cancer.mp4
  Artificial Intelligence and Modern Medical Practice- Do’s and Don’ts.mp4
  Bladder Cancer- Novel Insights and Recent Approvals.mp4
  Cancer Care Disparities in Puerto Rico.mp4
  Cancer Genetic Risk Factors- What’s New and What You Need to Know..mp4
  CAR-T Cell Therapy in Lymphomas- 7-Years Later.mp4
  Challenges in Lung Cancer Pathology- Biomarkers.mp4
  CLL- Therapeutic Advances in 2024.mp4
  Colorectal Cancer- Novel Treatment Paradigms.mp4
  Controversies in Colon Cancer- ctDNA in the Adjuvant Therapy of Colon Cancer and in the Management of Oligometastases (Against).mp4
  Controversies in Colon Cancer- ctDNA in the Adjuvant Therapy of Colon Cancer and in the Management of Oligometastases (in Favor).mp4
  Controversy in Breast Cancer- Should be pCR Be an Acceptable Endpoint for Approval of New Therapies for Early-Stage Breast Cance.mp4
  Controversy in Breast Cancer- Should be pCR Be an Acceptable Endpoint for Approval of New Therapies for Early-Stage Breast Cance_2.mp4
  Cost and Access to Novel Therapeutic Agents. Where Are The Obstacles..mp4
  ctDNA in Lung Cancer- Current State and Future Perspectives.mp4
  De Novo Acute Myeloid Leukemia.mp4
  Diabetes Management in the Face of Healthcare Disparities.mp4
  EGFR Exon 20 Insertions- Novel Agents.mp4
  End of Life Management- Oncologists’ Perspectives.mp4
  Equity and Equality for Minorities in Cancer Care.mp4
  Immunotherapy for Breast Cancer- Efficacy and Toxicity Considerations.mp4
  K-RAS Therapies in NSCLC.mp4
  Kidney Cancer- Novel Development in Targeted and Immunotherapy.mp4
  Leveraging NCODA Resources to Manage Patients on Oral Oncolytics.mp4
  Lifestyle Modifications in Reducing Risk of Recurrence.mp4
  los-noscm-2024-flyer.pdf
  Lung Cancer With EGFR Exon 19 and L858R Mutations- The Optimal Front Line Therapy.mp4
  Malignant Hematology and Use of Bi-specifics in Puerto Rico.mp4
  Melanoma- Novel Advances in Immunotherapy.mp4
  Metastatic Castration Resistant Prostate Cancer- Sequencing the Treatment.mp4
  Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy.mp4
  Neuro-Oncology- Novel Advances in Therapy.mp4
  Neurology Drug Update.mp4
  New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer.mp4
  Non Driver NSCLC-The Immunotherapy Strategy.mp4
  Novel Advances for Thyroid Carcinoma and Thymoma.mp4
  Novel Advances in T-Cell NHL Therapies.mp4
  Obesity Management with Incretin Therapies- Considerations for Patients with and without Type 2 Diabetes.mp4
  Optimal Surgical Approach in Early Stages NSCLC.mp4
  Other Driver Mutations- ROS-1, BRAF, MET and RET.mp4
  Pancreas, Hepatic and Cholangiocarcinoma- Advances in 2024.mp4
  Pharmacology I- What HemOnc Clinicians Must Know in Immunotherapy.mp4
  Prostate Cancer- Early and Locally Advanced Disease.mp4
  Role of Pharmacist in Vaccination–Challenges and Opportunities.mp4
  Screening in Lung Cancer- Challenges and Obstacles.mp4
  Sequencing Therapy in Relapsed-Refractory Myeloma Patients.mp4
  Small Cell Lung Cancer- Targeting This Difficult Target.mp4
  Soft Tissue and Osteosarcomas- Novel Advances in 2024.mp4
  Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR-ABL, FLT3, IDH1-2).mp4
  Testicular Cancer- The Old, The New, The Future.mp4
  Upfront Treatment for Common Ovarian Cancer (High Grade Serous) Versus Rare Histologies– Focus on PARPi and Other Targeted Ther.mp4
  Upper GI Cancer- Esophageal and Gastric-New Developments.mp4
  What Is Next After Osimertinib Progression..mp4